explore -WSS

explore

author：leisure time 2025-09-30 15:15:13 - browse：63

An illustrated portrait of Eli Lilly's David Ricks and Skovronsky – biotech and pharma coverage from STAT — Eli Lilly CEO David Ricks (left) and Chief Scientific Officer Daniel S. Skovronsky Molly Ferguson for STAT

The partnership that would shape Eli Lilly into one of the biggest success stories in the pharmaceutical industry began with conversations around a relatively minor acquisition.

At the time, David Ricks was running Lilly’s U.S. business and was part of the team charged with evaluating Avid Radiopharmaceuticals, which Lilly would go on to purchase in 2010 for a paltry $300 million — couch change for a multibillion-dollar firm. But what struck Ricks was not the company’s technology, for imaging Alzheimer’s plaques, but Avid’s CEO, Daniel S. Skovronsky.

“Dan’s different,” Ricks told STAT. “I had this sense immediately. Some people get in biotech for the cha-ching.” Skovronsky turned out to be a secret weapon. Within six months, Ricks had been promoted to run Lilly’s biomedicine unit and Skovronsky was working for him.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

WSS

Bird flu in dairy cattle: New measures to control spread to humans

HIPAA doesn't protect reproductive records from prosecutors

HIPAA doesn't protect reproductive records from prosecutors

U.K. decision on ALS drug has neurologists, advocates up in arms

First Opinion on colorectal cancer screening: letter and response

Trial using CRISPR to edit HIV out of cells disappoints

leisure time

explore

explore

Medical leaders decry Supreme Court decision on affirmative action

What to know about Saharan dust affecting the US and how it can affect health

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Organ transplantation is at a crossroads. Major reform is needed

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

How to save PrEP access — and even expand it

Marvel Studios reveals new trailer for 'The Marvels': Watch here

Apple is now the first public company to be valued at $3 trillion

Bird flu in dairy cattle: New measures to control spread to humans

hotspot

Bird flu reported in person exposed to presumably infected cattle

Study: Black kids more likely to die after surgery than white kids

Gut bacteria may contribute to kidney autoimmunity, study finds

Trial using CRISPR to edit HIV out of cells disappoints

Researchers test human milk's ability to repair gut microbiome

Pancreatic cancer is often deadly, but new discoveries are raising hope

Wikipedia

hotspot

focus

focus